tradingkey.logo

Tandem Diabetes Care Inc

TNDM
21.840USD
+0.370+1.72%
終値 11/25, 16:00ET15分遅れの株価
1.48B時価総額
損失額直近12ヶ月PER

Tandem Diabetes Care Inc

21.840
+0.370+1.72%

詳細情報 Tandem Diabetes Care Inc 企業名

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Tandem Diabetes Care Incの企業情報

企業コードTNDM
会社名Tandem Diabetes Care Inc
上場日Nov 13, 2013
最高経営責任者「CEO」Mr. John F. Sheridan
従業員数2650
証券種類Ordinary Share
決算期末Nov 13
本社所在地12400 High Bluff Drive
都市SAN DIEGO
証券取引所NASDAQ Global Market Consolidated
United States of America
郵便番号92130
電話番号18583666900
ウェブサイトhttps://www.tandemdiabetes.com/
企業コードTNDM
上場日Nov 13, 2013
最高経営責任者「CEO」Mr. John F. Sheridan

Tandem Diabetes Care Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5.03%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+4.05%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+4.75%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
32.38K
+0.11%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+18.30%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.05K
+6.59%
Mr. Jean-Claude (JC) Kyrillos
Mr. Jean-Claude (JC) Kyrillos
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
22.54K
+0.71%
Dr. Kathleen McGroddy-Goetz, Ph.D.
Dr. Kathleen McGroddy-Goetz, Ph.D.
Independent Director
Independent Director
17.85K
+32.58%
Ms. Peyton R. Howell
Ms. Peyton R. Howell
Independent Director
Independent Director
--
--
Mr. Joao Paulo Malagueira
Mr. Joao Paulo Malagueira
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
117.60K
+5.03%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
49.51K
+4.05%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
40.92K
+4.75%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
32.38K
+0.11%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+18.30%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
24.05K
+6.59%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Pump
223.74M
46.48%
Supplies and other
128.81M
26.76%
Supplies and other - Domestic
84.74M
17.60%
Supplies and other-International
44.06M
9.15%
Deferral for Tandem Choice program-Domestic
0.00
0.00%
地域別USD
会社名
収益
比率
Domestic
85.47M
17.76%
International
26.40M
5.49%
事業別
地域別
事業別USD
会社名
収益
比率
Pump
223.74M
46.48%
Supplies and other
128.81M
26.76%
Supplies and other - Domestic
84.74M
17.60%
Supplies and other-International
44.06M
9.15%
Deferral for Tandem Choice program-Domestic
0.00
0.00%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
他の
57.80%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.97%
The Vanguard Group, Inc.
10.40%
Sessa Capital
7.37%
ArrowMark Colorado Holdings, LLC
5.44%
GW&K Investment Management, LLC
4.01%
他の
57.80%
種類
株主統計
比率
Investment Advisor
55.96%
Investment Advisor/Hedge Fund
31.27%
Hedge Fund
20.88%
Research Firm
5.08%
Pension Fund
1.32%
Individual Investor
1.08%
Bank and Trust
0.93%
Venture Capital
0.11%
Family Office
0.07%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
659
81.42M
120.08%
-12.14M
2025Q2
684
76.82M
113.72%
-10.68M
2025Q1
717
75.41M
113.22%
-13.00M
2024Q4
729
74.63M
112.27%
-13.07M
2024Q3
730
75.54M
115.38%
-14.87M
2024Q2
754
76.14M
117.84%
-16.88M
2024Q1
762
76.49M
116.55%
-10.19M
2023Q4
800
72.80M
111.65%
-12.99M
2023Q3
790
71.79M
110.32%
-10.32M
2023Q2
793
70.34M
108.90%
-11.97M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
9.60M
14.2%
-159.92K
-1.64%
Jun 30, 2025
The Vanguard Group, Inc.
7.36M
10.89%
+77.66K
+1.07%
Jun 30, 2025
Sessa Capital
5.00M
7.4%
+533.69K
+11.95%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
2.70M
4%
-16.78K
-0.62%
Jun 30, 2025
GW&K Investment Management, LLC
2.89M
4.28%
+26.14K
+0.91%
Jun 30, 2025
State Street Investment Management (US)
2.65M
3.92%
-41.85K
-1.56%
Jun 30, 2025
Hood River Capital Management LLC
2.56M
3.8%
+252.93K
+10.94%
Jun 30, 2025
Paradice Investment Management LLC
1.77M
2.62%
+117.27K
+7.11%
Jun 30, 2025
Two Sigma Investments, LP
2.12M
3.14%
+799.78K
+60.54%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
SPDR S&P Health Care Equipment ETF
1.61%
Fidelity Digital Health ETF
1.15%
Global X HealthTech ETF
0.72%
Invesco S&P SmallCap Health Care ETF
0.52%
Invesco NASDAQ Future Gen 200 ETF
0.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.33%
Langar Global HealthTech ETF
0.19%
Inspire Small/Mid Cap ESG ETF
0.12%
Fidelity Enhanced Small Cap ETF
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.11%
詳細を見る
SPDR S&P Health Care Equipment ETF
比率1.61%
Fidelity Digital Health ETF
比率1.15%
Global X HealthTech ETF
比率0.72%
Invesco S&P SmallCap Health Care ETF
比率0.52%
Invesco NASDAQ Future Gen 200 ETF
比率0.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
比率0.33%
Langar Global HealthTech ETF
比率0.19%
Inspire Small/Mid Cap ESG ETF
比率0.12%
Fidelity Enhanced Small Cap ETF
比率0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
比率0.11%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Tandem Diabetes Care Incの上位5名の株主は誰ですか?

Tandem Diabetes Care Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は9.60M株を保有しており、これは全体の14.20%に相当します。
The Vanguard Group, Inc.は7.36M株を保有しており、これは全体の10.89%に相当します。
Sessa Capitalは5.00M株を保有しており、これは全体の7.40%に相当します。
ArrowMark Colorado Holdings, LLCは2.70M株を保有しており、これは全体の4.00%に相当します。
GW&K Investment Management, LLCは2.89M株を保有しており、これは全体の4.28%に相当します。

Tandem Diabetes Care Incの株主タイプ上位3種は何ですか?

Tandem Diabetes Care Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Sessa Capital

Tandem Diabetes Care Inc(TNDM)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Tandem Diabetes Care Incの株式を保有している機関は659社あり、保有株式の総市場価値は約81.42Mで、全体の120.08%を占めています。2025Q2と比較して、機関の持ち株は6.37%増加しています。

Tandem Diabetes Care Incの最大の収益源は何ですか?

FY2025Q2において、Pump部門がTandem Diabetes Care Incにとって最大の収益を生み出しており、その金額は223.74Mで、全収益の46.48%を占めています。
KeyAI